In general, elevated levels of PD-L1 in tumor cells have been linked with poor prognosis in different tumor types, such as breast cancer, head/neck cancer, gastric cancer, and prostate cancer [24,25,26,27,28,29]. The gene discussed is CD274; the disease is breast cancer.